A detailed history of Bridgeway Capital Management, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 85,000 shares of ANNX stock, worth $592,450. This represents 0.01% of its overall portfolio holdings.

Number of Shares
85,000
Previous 177,500 52.11%
Holding current value
$592,450
Previous $1.27 Million 67.3%
% of portfolio
0.01%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.33 - $6.79 $400,525 - $628,075
-92,500 Reduced 52.11%
85,000 $416,000
Q1 2024

May 15, 2024

SELL
$4.03 - $7.81 $8,060 - $15,620
-2,000 Reduced 1.11%
177,500 $1.27 Million
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $23,472 - $66,672
14,400 Added 8.72%
179,500 $814,000
Q3 2023

Nov 14, 2023

BUY
$2.13 - $3.84 $154,638 - $278,784
72,600 Added 78.49%
165,100 $389,000
Q2 2023

Aug 14, 2023

BUY
$2.1 - $6.37 $194,250 - $589,225
92,500 New
92,500 $325,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $332M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.